STX2 and hemolytic-uremic syndrome: In a mouse model of HUS obtained by Stx2/LPS-coinjection, we found that Stx2 was able to activate complement through the alternative pathway, favoring exuberant glomerular C3b deposits and the generation of C3a [22,23].